尿溶蛋白3A(UPK3A)多克隆抗体

Polyclonal Antibody to Uroplakin 3A (UPK3A)

UPIII; UPK3

  • 尿溶蛋白3A(UPK3A)多克隆抗体 产品包装(模拟)
  • 尿溶蛋白3A(UPK3A)多克隆抗体 产品包装(模拟)
  • 尿溶蛋白3A(UPK3A)多克隆抗体 Used in DAB staining on fromalin fixed paraffin- embedded kidney tissue
  • PAF558Ra01.jpg Figure. Western Blot; Sample: Recombinant UPK3A, Rat.
  • 尿溶蛋白3A(UPK3A)多克隆抗体 Western Blot; Sample: Rat Bladder lysate; <br/>Primary Ab: 1µg/ml Rabbit Anti-Rat UPK3A Antibody<br/>Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
  • 尿溶蛋白3A(UPK3A)多克隆抗体 Western Blot; Sample: Mouse Bladder lysate; <br/>Primary Ab: 1µg/ml Rabbit Anti-Rat UPK3A Antibody<br/>Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
  • 尿溶蛋白3A(UPK3A)多克隆抗体 Western Blot; Sample: Human Serum; <br/>Primary Ab: 1µg/ml Rabbit Anti-Rat UPK3A Antibody<br/>Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19) Selected
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对UPK3A的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别UPK3A。

用法

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Rattus norvegicus (Rat，大鼠) 应用(仅供研究使用，不用于临床诊断！)
RPF558Ra01 尿溶蛋白3A(UPK3A)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAF558Ra01 尿溶蛋白3A(UPK3A)多克隆抗体 WB; IHC; ICC; IP.
MAF558Ra21 尿溶蛋白3A(UPK3A)单克隆抗体 WB; IHC; ICC; IP.
SEF558Ra 尿溶蛋白3A(UPK3A)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMF558Ra 尿溶蛋白3A(UPK3A)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Biomed Research International Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis [Pubmed:30069482]
International Journal of Urology Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti‐inflammatory effects [Pubmed:29268303]
. Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases [34944460]
留言咨询